Medivizor

Title of notification

Here comes the notification
X
 
icon
icon
prostate cancer | Research | Treatment | 6 pages | source: Journal of Urology | Added Sep 29, 2019

Preventing osteoporosis with Toremifene in men with prostate cancer treated with androgen deprivation therapy (ADT)

This article presents the results of a phase III clinical trial that evaluated the safety and efficacy of Toremifene (Acapodene) for lowering fracture risk in men with prostate cancer receiving androgen deprivation therapy (ADT). The risk of spinal fractures was significantly reduced in patients who received Toremifene.

icon
erectile dysfunction | Research | 10 pages | source: The journal of sexual medicine | Added Sep 28, 2019

Erectile dysfunction: An early sign of heart disease?

This study investigated the relationship between erectile dysfunction and cardiovascular risk, specifically plaque build-up in major arteries.

Researchers concluded that men with erectile dysfunction are at increased risk of cardiovascular disease, and recommend increased screening.

icon
icon
erectile dysfunction | Research | Treatment | 10 pages | source: Current opinion in urology | Added Sep 26, 2019

Overview of local treatments for erectile dysfunction

This study reviewed evidence on local treatments for erectile dysfunction.

Researchers concluded that local treatment with alprostadil (Muse, Vitaros) is a safe and effective alternative treatment option for erectile dysfunction.

icon
icon
prostate cancer | Research | Treatment | 13 pages | source: Journal of clinical oncology | Added Sep 19, 2019

More effective androgen blockade possible?

This study examined the effectiveness of combined androgen blockade in the treatment of prostate cancer.

icon
prostate cancer | Research | 10 pages | source: Lancet (London, England) | Added Sep 17, 2019

Surviving cancer – is there a greater risk of cardiovascular disease long-term?

This study investigated if there is a higher risk of cardiovascular disease (CVD) in cancer survivors. 
They found that cancer survivors have a higher risk of CVD.

icon
prostate cancer | Research | 9 pages | source: British Journal of Cancer | Added Sep 15, 2019

Psychological and physical therapy can improve quality of life

This article examined the use of a physical and psychosocial rehabilitation program to improve urinary dysfunction and patient quality of life following radiotherapy for the treatment of prostate cancer.

icon
icon
erectile dysfunction | Research | Treatment | 10 pages | source: The journal of sexual medicine | Added Sep 14, 2019

Viagra is safe and effective regardless of age

This study examined the safety and effectiveness of sildenafil (Viagra) across different age groups. Researchers reported improved erectile function in all age groups with a low rate of side effects.

icon
icon
erectile dysfunction | Research | Treatment | 10 pages | source: Journal of Urology | Added Sep 11, 2019

Can shockwave treatment improve erectile function?

This study evaluated the use of low-intensity shockwave treatment (LIST) for erectile dysfunction.

Researchers concluded that LIST is effective at improving erectile function, even in severe cases.

icon
icon
prostate cancer | Research | Lifestyle | 10 pages | source: European Urology | Added Sep 10, 2019

Physical activity affects long-term survival after prostate cancer

This study examined the effect of physical activity on long-term prostate cancer survival. Researchers reported a strong link between higher physical activity and increasing survival after prostate cancer diagnosis.

icon
icon
prostate cancer | Research | Treatment | 9 pages | source: World Journal of Urology | Added Sep 08, 2019

Reviewing the cardicovascular effects of androgen deprivation therapy in prostate cancer

The authors aimed to determine whether patients who received androgen deprivation therapy were more at risk of experiencing cardiovascular events.

View

Conditions

Category

  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon

Was this helpful?